Effects of tryptophan loading on human cognition, mood, and sleep BY Silber, JAJ Schmitt Neuroscience & biobehavioral reviews 34 (3), 387-407, 2010 | 333 | 2010 |
Serotonin and human cognitive performance JAJ Schmitt, M Wingen, JG Ramaekers, EAT Evers, WJ Riedel Current pharmaceutical design 12 (20), 2473-2486, 2006 | 312 | 2006 |
Caffeine improves physical and cognitive performance during exhaustive exercise EEF Hogervorst, S Bandelow, J Schmitt, ROY Jentjens, M Oliveira, ... Medicine & Science in Sports & Exercise 40 (10), 1841-1851, 2008 | 279 | 2008 |
Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers JAJ Schmitt, BL Jorissen, S Sobczak, MPJ van Boxtel, E Hogervorst, ... Journal of psychopharmacology 14 (1), 21-29, 2000 | 260 | 2000 |
Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors JAJ Schmitt, MJ Kruizinga, WJ Riedel Journal of Psychopharmacology 15 (3), 173-179, 2001 | 166 | 2001 |
Effects of drinking supplementary water at school on cognitive performance in children R Fadda, G Rapinett, D Grathwohl, M Parisi, R Fanari, CM Calò, J Schmitt Appetite 59 (3), 730-737, 2012 | 155 | 2012 |
Effects of acute tryptophan depletion on mood and facial emotion perception related brain activation and performance in healthy women with and without a family history of … FM Van der Veen, EAT Evers, NEP Deutz, JAJ Schmitt Neuropsychopharmacology 32 (1), 216-224, 2007 | 152 | 2007 |
Tryptophan, mood, and cognitive function WJ Riedel, T Klaassen, JAJ Schmitt Brain, behavior, and immunity 16 (5), 581-589, 2002 | 142 | 2002 |
The effects of habitual caffeine use on cognitive change: a longitudinal perspective MPJ Van Boxtel, JAJ Schmitt, H Bosma, J Jolles Pharmacology Biochemistry and Behavior 75 (4), 921-927, 2003 | 136 | 2003 |
Does coffee enriched with chlorogenic acids improve mood and cognition after acute administration in healthy elderly? A pilot study V Cropley, R Croft, B Silber, C Neale, A Scholey, C Stough, J Schmitt Psychopharmacology 219, 737-749, 2012 | 130 | 2012 |
Driving impairment in depressed patients receiving long-term antidepressant treatment M Wingen, JG Ramaekers, JAJ Schmitt Psychopharmacology 188, 84-91, 2006 | 112 | 2006 |
General methodological considerations for the assessment of nutritional influences on human cognitive functions JAJ Schmitt, D Benton, KW Kallus European Journal of Nutrition 44, 459-464, 2005 | 110 | 2005 |
Effects of a novel method of acute tryptophan depletion on plasma tryptophan and cognitive performance in healthy volunteers EAT Evers, DE Tillie, FM Van Der Veen, CK Lieben, J Jolles, NEP Deutz, ... Psychopharmacology 177, 217-223, 2004 | 96 | 2004 |
Sex differences in the effect of acute tryptophan depletion on declarative episodic memory: a pooled analysis of nine studies A Sambeth, A Blokland, CJ Harmer, TOC Kilkens, PJ Nathan, RJ Porter, ... Neuroscience & Biobehavioral Reviews 31 (4), 516-529, 2007 | 95 | 2007 |
Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment WJ Riedel, K Eikmans, A Heldens, JAJ Schmitt Journal of Psychopharmacology 19 (1), 12-20, 2005 | 91 | 2005 |
Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man JAJ Schmitt, JG Ramaekers, MJ Kruizinga, MPJ van Boxtel, ... Journal of psychopharmacology 16 (3), 207-214, 2002 | 90 | 2002 |
The effect of acute tryptophan depletion on the BOLD response during performance monitoring and response inhibition in healthy male volunteers EAT Evers, FM Van der Veen, JA Van Deursen, JAJ Schmitt, NEP Deutz, ... Psychopharmacology 187, 200-208, 2006 | 88 | 2006 |
Acute tryptophan depletion improves performance and modulates the BOLD response during a Stroop task in healthy females EAT Evers, FM van der Veen, J Jolles, NEP Deutz, JAJ Schmitt Neuroimage 32 (1), 248-255, 2006 | 85 | 2006 |
Pronounced cognitive deficits following an intravenous L-tryptophan challenge in first-degree relatives of bipolar patients compared to healthy controls S Sobczak, A Honig, JAJ Schmitt, WJ Riedel Neuropsychopharmacology 28 (4), 711-719, 2003 | 79 | 2003 |
The pharmacokinetic and pharmacodynamic effects of SL65. 1498, a GABA-A 2, 3 selective agonist, in comparison with lorazepam in healthy volunteers SL De Haas, KL Franson, JAJ Schmitt, AF Cohen, JB Fau, C Dubruc, ... Journal of Psychopharmacology 23 (6), 625-632, 2009 | 78 | 2009 |